Neuro-trauma A Cost Analysis of Neurotropic Substance use ( codeine+ tramadol ) among Commercial Bus Drivers who were Managed as Road Traffic Head Injury Victims in a Tertiary Center in South-West, Nigeria


Authors : Dr. Idowu E.O

Volume/Issue : Volume 6 - 2021, Issue 10 - October

Google Scholar : http://bitly.ws/gu88

Scribd : https://bit.ly/30gqlmP

The study assessed the economic burden of neuro-tropic substance use ( tramadol+ codeine) among commercial bus drivers who presented as head injury victims in a prestigious tertiary center in Ibadan, Nigeria, Sub-saharan Africa. The study adopted a snowballing/purposive sampling method to obtain data. The interview was done with 386 road traffic injury victims( commercial bus drivers) admitted over a 4- month period to the randomly selected study center using a structured questionairre. The result showed that average cost per patient for road traffic head injury treatment( neuro-trauma care) was 346 US dollars with an average of 30 US dollars on tramadol+ codeine purchase aside the medical expenditure. Prevalence of catastrophic out-of-pocket spending was over 90% thereby rendering victims impoverished. It is recommended that clinical neuro-toxicology units be established in hospitals for routine and emergency toxicology screens for licensure to qualify or be disqualified from public commercial driving and for neuro-rehabs follow-up care alongside medical insurance for the citizenry with implemented laws and regulations guiding use of codeine+tramadol and other neuro-tropic medications of public health concern.

Keywords : mroad traffic injury, neuro-toxicology, codeine+tramadol, neurotropic substances, neurotrauma.

CALL FOR PAPERS


Paper Submission Last Date
31 - May - 2022

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe